KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Assets (2018 - 2025)

Bionano Genomics' Return on Assets history spans 7 years, with the latest figure at 0.5% for Q3 2025.

  • For Q3 2025, Return on Assets rose 76.0% year-over-year to 0.5%; the TTM value through Sep 2025 reached 0.5%, up 76.0%, while the annual FY2024 figure was 0.77%, 12.0% up from the prior year.
  • Return on Assets for Q3 2025 was 0.5% at Bionano Genomics, up from 0.96% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.14% in Q2 2021 and bottomed at 1.42% in Q2 2024.
  • The 5-year median for Return on Assets is 0.5% (2025), against an average of 0.68%.
  • The largest annual shift saw Return on Assets soared 128bps in 2021 before it crashed -90bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.2% in 2021, then tumbled by -114bps to 0.42% in 2022, then tumbled by -179bps to 1.17% in 2023, then fell by -16bps to 1.37% in 2024, then soared by 64bps to 0.5% in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Return on Assets are 0.5% (Q3 2025), 0.96% (Q2 2025), and 1.08% (Q1 2025).